These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17380444)

  • 1. Rituximab alone was effective for the treatment of a diffuse large B-cell lymphoma associated with hemophagocytic syndrome.
    Sano T; Sakai H; Takimoto K; Ohno H
    Int J Clin Oncol; 2007 Feb; 12(1):59-62. PubMed ID: 17380444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary bilateral adrenal lymphoma revealed by hemophagocytic syndrome.
    Alaoua A; Gilbert G; Ghannouchi N; Houchlef M; Letaief A; Bahri F
    Ann Endocrinol (Paris); 2011 Jun; 72(3):247-50. PubMed ID: 21640976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful autologous peripheral blood stem cell transplantation for a patient with primary adrenal lymphoma with hemophagocytic syndrome.
    Uehara T; Yokota A; Onoda M; Yamamoto K; Terano T
    Clin Lymphoma Myeloma; 2008 Jun; 8(3):184-7. PubMed ID: 18650184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relapse of diffuse large B cell lymphoma to CD20-negative multiple cutaneous tumors immediately after anti-CD20 monoclonal antibody (rituximab) therapy].
    Iguchi T; Miyazawa K; Okabe S; Kawakubo K; Shimamoto T; Kuriyama Y; Ito Y; Kimura Y; Ohyashiki K; Serizawa H; Iwaya K; Mukai K
    Rinsho Ketsueki; 2004 Oct; 45(10):1129-34. PubMed ID: 15553050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse large B-cell primary gastric lymphoma treated successfully with the CD20 monoclonal antibody (rituximab): a case with severe liver dysfunction due to liver cirrhosis and hepatocellular carcinoma.
    Nakai S; Masaki T; Shintani T; Deguchi A; Kimura Y; Himoto T; Kurokohchi K; Watanabe S; Kuriyama S
    Oncol Rep; 2005 Jun; 13(6):1065-8. PubMed ID: 15870922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
    Coiffier B; Lepage E; Briere J; Herbrecht R; Tilly H; Bouabdallah R; Morel P; Van Den Neste E; Salles G; Gaulard P; Reyes F; Lederlin P; Gisselbrecht C
    N Engl J Med; 2002 Jan; 346(4):235-42. PubMed ID: 11807147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab for bone lymphoma.
    Savage DG; Staron R
    Ann Intern Med; 2001 Jun; 134(12):1156-7. PubMed ID: 11412072
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment of catastrophic antiphospholipid antibody syndrome (CAPS) associated with splenic marginal-zone lymphoma with low-molecular weight heparin, rituximab and bendamustine.
    Manner H; Jung B; Tonassi L; Hackenberg U; Plum N; Josten KM; Kirchmaier CM; Frickhofen N
    Am J Med Sci; 2008 May; 335(5):394-7. PubMed ID: 18480659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma].
    Wu HJ; Zhang QY; Chen DF; Guan XJ; Zhang BL; Ma J
    Ai Zheng; 2005 Dec; 24(12):1498-502. PubMed ID: 16351800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diffuse B-cell lymphoma associated with hemophagocytic syndrome].
    Suzuki T; Nonaka Y; Hayashi T; Nomura T; Ogawa M; Mori S
    Rinsho Ketsueki; 1998 Jan; 39(1):59-65. PubMed ID: 9492555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A complete response with rituximab in metastatic diffuse large B-cell lymphoma of the testis: case report.
    Autorino R; Lamendola MG; De Sio M; Di Trolio RA; Ferraraccio F; Di Lorenzo G
    Int J Immunopathol Pharmacol; 2007; 20(2):401-3. PubMed ID: 17624254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adult T-cell leukemia-lymphoma developed from an HTLV-1 carrier during treatment of B-cell lymphoma-associated hemophagocytic syndrome].
    Nagao T; Takahashi N; Saitoh H; Noguchi S; Guo YM; Ito M; Watanabe A; Fujishima N; Kameoka Y; Tagawa H; Hirokawa M; Sawada K
    Rinsho Ketsueki; 2012 Dec; 53(12):2008-12. PubMed ID: 23318967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary splenic lymphoma associated with hemophagocytic lymphohistiocytosis complicated with splenic rupture.
    Han SM; Teng CL; Hwang GY; Chou G; Tsai CA
    J Chin Med Assoc; 2008 Apr; 71(4):210-3. PubMed ID: 18436505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large gastrosplenic fistula after effective treatment of abdominal diffuse large-B-cell lymphoma.
    Palmowski M; Zechmann C; Satzl S; Bartling S; Hallscheidt P
    Ann Hematol; 2008 Apr; 87(4):337-8. PubMed ID: 17929016
    [No Abstract]   [Full Text] [Related]  

  • 15. [A case of malignant lymphoma associated with diffuse pulmonary involvement successfully treated with rituximab].
    Kataoka T; Ishida Y; Kurokawa R; Takeshita S; Ohta K; Nishimura Y; Yokoyama M
    Nihon Kokyuki Gakkai Zasshi; 2003 Dec; 41(12):899-904. PubMed ID: 14727553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD5-positive diffuse large B-cell lymphoma with an unusual phenotype: Cytoplasmic CD20 (+), surface CD20 (-).
    Yokose N; Shioi Y; Sugisaki Y; Ohaki Y; Ogata K; Dan K
    Leuk Lymphoma; 2006 Jul; 47(7):1415-7. PubMed ID: 16923582
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytomegalovirus enterocolitis in a patient with diffuse large B-cell lymphoma after chemotherapy with rituximab.
    Seewoodhary J
    World J Gastroenterol; 2006 Dec; 12(45):7391. PubMed ID: 17143963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma.
    Habermann TM; Weller EA; Morrison VA; Gascoyne RD; Cassileth PA; Cohn JB; Dakhil SR; Woda B; Fisher RI; Peterson BA; Horning SJ
    J Clin Oncol; 2006 Jul; 24(19):3121-7. PubMed ID: 16754935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group.
    Pfreundschuh M; Trümper L; Osterborg A; Pettengell R; Trneny M; Imrie K; Ma D; Gill D; Walewski J; Zinzani PL; Stahel R; Kvaloy S; Shpilberg O; Jaeger U; Hansen M; Lehtinen T; López-Guillermo A; Corrado C; Scheliga A; Milpied N; Mendila M; Rashford M; Kuhnt E; Loeffler M;
    Lancet Oncol; 2006 May; 7(5):379-91. PubMed ID: 16648042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cutaneous large B-cell lymphoma of the legs: a distinct clinical pathologic entity treated with CD20 monoclonal antibody (rituximab).
    Aboulafia DM
    Am J Clin Oncol; 2001 Jun; 24(3):237-40. PubMed ID: 11404492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.